For US pharma companies, developing lyophilized and liquid formulations is crucial to achieving their drug development aims. Recognizing this, Biopharma Technology LLC’s CDMO lyophilization services and solutions future proof these objectives by enabling organizations to create stable and long-lasting products at scale.
Our services include:
- Material characterization (including FDM/ lyophilization microscopy)
- Proof-of-concept studies
- Formulation development for liquid formulations and lyophilized products
- Process audits, characterization and development
- Lyophilization design space
- Stability studies
- Comparative process studies
- Technical transfer and scale up
Download a copy of our Pharmaceutical Services & Solutions overview brochure, click here
Why Choose Biopharma Technology LLC?
By partnering with Biopharma Technology LLC, our highly-experienced team provides you with expertise and advice at every stage of your research and development (R&D) project – from product and process optimization through to troubleshooting and scale up.
Biopharma Technology LLC’s flexible pharma CDMO services are tailored to the specific requirements of organizations working across the pharmaceutical, biotech and medical devices industries. We can support the development of numerous product types, including:
- Antibiotics
- Hormones
- Peptide
- Oligonucleotides
- Proteins
- Monoclonal antibodies
- ADCs
- Nanoparticles
- Viral vectors
- mRNA vaccines
- Cells and stem cells
- Human and animal tissues
- Plasma derivate product
- Microbiome
- Probiotics
- Aerobic and anaerobic bacteria
- Collagen